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To identify novel susceptibility loci for Crohn disease (CD), we undertook a genome-wide association study with more
than 300,000 SNPs characterized in 547 patients and 928 controls. We found three chromosome regions that provided
evidence of disease association with p-values between 10
 6 and 10
 9. Two of these (IL23R on Chromosome 1 and
CARD15 on Chromosome 16) correspond to genes previously reported to be associated with CD. In addition, a 250-kb
region of Chromosome 5p13.1 was found to contain multiple markers with strongly suggestive evidence of disease
association (including four markers with p , 10
 7). We replicated the results for 5p13.1 by studying 1,266 additional
CD patients, 559 additional controls, and 428 trios. Significant evidence of association (p , 4310
 4) was found in case/
control comparisons with the replication data, while associated alleles were over-transmitted to affected offspring (p ,
0.05), thus confirming that the 5p13.1 locus contributes to CD susceptibility. The CD-associated 250-kb region was
saturated with 111 SNP markers. Haplotype analysis supports a complex locus architecture with multiple variants
contributing to disease susceptibility. The novel 5p13.1 CD locus is contained within a 1.25-Mb gene desert. We present
evidence that disease-associated alleles correlate with quantitative expression levels of the prostaglandin receptor
EP4, PTGER4, the gene that resides closest to the associated region. Our results identify a major new susceptibility
locus for CD, and suggest that genetic variants associated with disease risk at this locus could modulate cis-acting
regulatory elements of PTGER4.
Citation: Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1
and modulates expression of PTGER4. PLoS Genet 3(4): e58. doi:10.1371/journal.pgen.0030058
Introduction
Crohn disease (CD) is a chronic relapsing inﬂammatory
disorder of the intestinal tract, described for the ﬁrst time in
the 1920s [1]. Lifetime prevalence has increased to current
estimates of ;0.15% in Caucasians. The precise environ-
mental causes underlying this rise remain essentially un-
known, but familial clustering and twin studies clearly
identify an inherited component to predisposition. More
than ten susceptibility loci have been identiﬁed by linkage
and/or association studies and convincing causative mutations
have been reported, particularly in CARD15 [2–3]. As known
loci don’t fully account for the genetic risk for CD we
performed a genome-wide association scan (GWA) to con-
tribute to the identiﬁcation of additional susceptibility loci.
Results/Discussion
Genotype data from the Illumina HumanHap300 Genotyp-
ing Beadchip [4] were obtained on 547 Caucasian CD patients
from Belgium and compared to genotypes for 928 healthy
controls from Belgium and France. Genotype call rates were
.93% for all individuals included in the study. Of the total
317,497 SNPs available, 15,046 with genotyping success rate of
less than 96% or deviating from Hardy-Weinberg propor-
tions in controls (Fisher’s exact test p   10
 3) were eliminated
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generate spurious associations. For the remaining 302,451
SNPs, we compared allele frequencies between cases and
controls as outlined in Methods.
Figure 1 shows the 10,000 most signiﬁcant p-values
obtained across the human genome. Regions on Chromo-
somes 1, 5, and 16 harbored clusters of markers with
suggestive evidence of association at signiﬁcance levels
between 10
 6 and 10
 10.T h es i g n i ﬁ c a n c eo ft e s t so f
association with these markers remained within this range
after controlling for possible effects of population structure
using a backwards stepwise regression [5]. The strongest
association was found with markers of the IL23R gene on
Chromosome 1, which has recently been identiﬁed as a novel
CD susceptibility locus in a case-control and family-based
association study of Caucasian and Jewish cohorts [6]. In our
data, two markers of the IL23R gene, rs11209026 and
rs11465804, gave the most signiﬁcant association signals (p
, 10
 9). Rs11209026 corresponds to an Arg381Gln substitu-
tion in IL23R while rs11465804 is intronic and in strong
linkage disequilibrium (LD) with the former marker. A
marker within the CARD15 gene on Chromosome 16, which
is the ﬁrst susceptibility gene to have been identiﬁed in CD
[3], also showed suggestive evidence of association (rs5743289;
p , 10
 6). We also examined the results of the GWA with
respect to other previously reported susceptibility loci,
including OCTN [7], DLG5 [8], TNFSF15 [9], and ATG16L1
[10]. None of these obtained a similar level of signiﬁcance for
association in our study. Genotyping our cohorts for other
SNPs at these loci that are reported in the literature to be
associated with CD did not improve the signals, with the
exception of rs224188 corresponding to a Thr-to-Ala
substitution within ATGL16L1 (p , 2 3 10
 4), thus providing
conﬁrmation of this novel susceptibility locus for the ﬁrst
time [10].
On Chromosome 5p13.1, we identiﬁed a region of
Figure 1. Results of the GWA for CD
p-values ( log[p]) for the 10,000 best SNPs out of 302,451 are shown (gray circles). The position of previously described susceptibility loci are marked by
red arrows. The p-values obtained in our cohorts with the reportedly associated SNPs/mutations are shown by the red dots, and the corresponding
odds ratios are indicated. The p-values obtained with SNPs included in the Illumina panel  50 kb from these SNPs/mutations are marked by black
circles. SNPs genotyped in the confirmation cohort are shown as green dots.
doi:10.1371/journal.pgen.0030058.g001
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Author Summary
Individual susceptibility to many common diseases is determined by
a combination of environmental and genetic factors. Identifying
these genetic risk factors is one of the most important objectives of
modern medical genetics, as it paves the way towards personalized
medicine and drug target identification. Recent advances in SNP
genotyping technology allows systematic association scanning of
the entire genome for the detection of novel susceptibility loci. We
herein apply this approach to Crohn disease, which afflicts an
estimated 0.15% of the people in the developed world and identify
a novel susceptibility locus on Chromosome 5. A unique feature of
the novel 5p13.1 locus is that it coincides with a 1.25-Mb gene
desert. We present evidence that genetic variants at this locus
influence the expression levels of the closest gene, PTGER4, located
270 kb away, in the direction of the centromere. PTGER4 encodes
the prostaglandin receptor EP4 and is a strong candidate
susceptibility gene for Crohn disease as PTGER4 knock-out mice
have increased susceptibility to colitis.approximately 250 kb that contained six markers with p ,
10
 6 in the association test (Figure S1). This region has not
previously been reported as a CD susceptibility locus. We
selected ten markers from the regions of IL23R and 5p13.1
for conﬁrmation genotyping in up to 1,266 additional
Caucasian CD patients and 559 additional controls. The
IL23R locus was included in the conﬁrmation genotyping as it
had not yet been reported at the time of our study [6]. The
associations at these two loci were clearly replicated with p-
values as low as 4.2 3 10
 7 at the IL23R and 3.7 3 10
 4 at
5p13.1 (Table 1). In the combined data from the GWA and
replication studies, we obtained p-values as low as 2.2310
 18
at IL23R and 2.1 3 10
 12 at the 5p13.1 locus. In addition, we
genotyped trios with non-affected parents for the same SNPs
to perform a transmission disequilibrium test (TDT). The ten
SNPs were typed on 137 trios with affected offspring included
in the case-control study, while two of the 5p13.1 SNPs were
typed on an additional 291 independent trios, also originat-
ing from Belgium. Signiﬁcant over-transmission of the
associated alleles were found at both loci, thus providing
additional conﬁrmatory evidence in support of the IL23R1
and 5p13.1 susceptibility loci (Table 1).
To further characterize the novel 5p13.1 locus, we
genotyped a subset of 1,092 CD patients and 374 Belgian
controls for 111 markers (average interval: 2.3 kb) spanning
the 250-kb segment. We determined the most likely linkage
phase for each individual using PHASE [11], and used the
corresponding haplotype frequencies to quantify the level of
Table 1. Results of Primary and Confirmatory Association Analysis and TDT for the IL23R and 5p13.1 Loci
Locus SNP
a Primary Data Confirmatory Data Combined TDT
Controls
b Cases
c Controls
b Cases
c Controls
b Cases
c
IL23R rs11465804 0.915 0.971 0.934 0.970 0.922 0.970 16:4
d
(67475114) 923 553 555 928 1,478 1,481 137
e
0.98 3.2E–8 0.96 1.7E–5 0.99 3.5E–15 0.04
f
3.00 2.30 2.74
rs11209026 0.918 0.972 0.934 0.972 0.924 0.972 17:5
(67478546) 906 550 550 1,255 1,456 1,807 135
Arg381Gln 0.93 1.5E–8 0.64 4.2E–7 0.99 2.2E–18 0.045
3.20 2.48 2.92
rs1343151 0.641 0.712 0.655 0.722 0.646 0.719 76:39
(67491717) 928 554 556 1,266 1,484 1,820 137
0.88 3.0E–4 0.32 2.9E–4 0.87 2.3E–9 0.0003
1.38 1.36 1.40
rs10889677 0.291 0.354 0.31 0.36 0.30 0.36 69:44
(67497708) 927 550 559 1,263 1,486 1,813 135
0.91 0.002 0.75 0.015 0.73 2.4E–6 0.009
1.33 1.25 1.31
5p13.1 rs348601 0.589 0.686 0.629 0.668 0.604 0.673 72:64
(40355763) 928 552 545 1,261 1,473 1,813 138
0.24 5.1E–7 0.53 0.067 0.82 6.6E–7 0.05
1.54 1.19 1.36
rs1002922 0.665 0.762 0.697 0.741 0.675 0.747 62:44
(40422312) 903 550 441 1,212 1,344 1,762 134
0.46 9.1E–8 0.45 0.04 0.95 1.7E–9 0.040
1.63 1.25 1.43
rs4613763 0.120 0.191 0.139 0.183 0.127 0.185 139:113
(40428485) 929 553 545 1,247 1,474 1,800 428
0.99 6.1E–7 0.13 6.2E–3 0.37 1.2E–9 0.050
1.74 1.38 1.56
rs10512734 0.666 0.762 0.685 0.742 0.673 0.748 61:46
(40429362) 929 553 543 1,236 1,472 1,789 136
0.30 9.7E–8 0.91 1.8E–3 0.62 9.2E–11 0.073
1.63 1.33 1.45
rs1373692 0.585 0.690 0.607 0.674 0.593 0.679 214:177
(40466940) 929 554 552 1,235 1,481 1,789 428
0.13 4.1E–8 0.89 3.7E–4 0.43 2.1E–12 0.030
1.59 1.35 1.46
rs4495224 0.651 0.746 0.675 0.708 0.659 0.720 66:43
(40513272) 926 552 544 1,237 1,470 1,789 137
0.60 2.2E–7 0.99 0.134 0.71 6.6E–7 0.013
1.59 1.17 1.33
aChromosomal position from March 2006 assembly indicated in parentheses.
bFor each SNP: line 1, Allelic frequency of risk allele; line 2, number of individuals with genotype; and line 3, p-value of Hardy-Weinberg proportions (Fisher’s exact test).
cFor each SNP: line 1, Allelic frequency of risk allele; line 2, number of individuals with genotype; line 3, p-value of allelic association (chi-squared test); and line 4, odds ratio.
dTimes transmitted:times non-transmitted.
eNumber of genotyped trios.
fp-value of segregation distortion (one-sided chi-squared test).
Results under Primary Data were obtained after re-genotyping of the initial samples using the Taqman assay conducted to verify the Illumina genotypes.
doi:10.1371/journal.pgen.0030058.t001
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Whole Genome Association for Crohn DiseaseLD between all marker pairs. The 250 kb encompass ﬁve
clearly delineated LD blocks, the central one (block III) being
the largest and spanning 122 kb (Figure 2A). We ﬁrst
performed single-marker association analyses. The strongest
effects were observed within the 122-kb block III with several
SNPs yielding p-values ,10
 5. p-values ,10
 3 and 10
 4 were
observed in ﬂanking blocks II and IV, respectively (Figure 2B).
We then performed haplotype analysis of the region spanned
by blocks II to IV. For block III, 20 haplotypes accounted for
93% of the observed chromosomes. These could be grouped
in three clades comprising respectively six (IIIA), six (IIIB),
and two (IIIC) haplotypes, plus a group of six haplotypes that
apparently originated from various recombination events.
Likewise, evaluation of block II revealed three clades (with
respectively two [IIA], three [IIB], and two [IIC] haplotypes)
and two recombinant haplotypes, while block IV was
characterized by two clades with two (IVA) and one (IVB)
haplotype respectively. We compared the clade frequencies in
cases and controls at intervals bounded by ancestral
recombination events (Figure 2C). In agreement with the
results of the single-marker analysis, the most signiﬁcant
associations were found in block III followed by IV and II. To
verify whether the entire 5p13.1 effect could be attributed to
block III (i.e., the effects observed for blocks II and IV would
Figure 2. LD, Association and Haplotype Analyses of the 5p13.1. Susceptibility Locus
(A) Pair-wise LD analysis between the 111 SNPs in the 250-kb window.
r
2 (lower left) and D9 (upper right) values were computed using standard procedures from the genotypes phased with PHASE [11]. Values .0.93 are
marked in red, values  0.93 in blue. The five LD blocks are easily identified and marked by corresponding boxes I to V.
(B) Red dots: results of single-marker association analyses for CD using 111 SNPs located in a 250-kb window spanning the positions of the most
significant 5p13.1 markers in the GWA. The results are expressed as log(1/p), where p corresponds to the p-value of the association determined by chi-
squared analysis. The positions of the 111 markers are indicated by the small triangles. The limits between the LD blocks (I–V) are indicated. Blue
diamonds: log(1/p) values of the effect of marker genotype on PTGER4 expression levels for the 26 HumanHap300 Genotyping Beadchip SNPs mapping
to the 250-kb window. Values are only shown when exceeding 2.
(C) Haplotype analysis of LD blocks II, III, and IV. Haplotypes accounting jointly for .93% of studied chromosomes are shown. The ancestral allele is in
grey when known. Within each block, similar haplotypes are grouped in ‘‘clades’’ (e.g., IIA, IIB, and IIC) marked by different colors (red, blue or green).
For blocks II and III, supposedly recombinant haplotypes are represented under the major clades and colored accordingly. The frequency of the
corresponding haplotypes (black and white) and clades (colored) in CD patients and controls are given. p-values (chi-squared test) of the clade-based
association tests for CD are given underneath for intervals bounded by recombination events. The approximate positions of within-block
recombinations are marked by vertical lines between p-values. The two haplotypes forming the IIIBa sub-clade are indicated.
CD, CD patients; CTR, controls.
doi:10.1371/journal.pgen.0030058.g002
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Whole Genome Association for Crohn Diseasebe mere echos of the block III effect), we performed a multi-
variate analysis as described in Methods. The clade effects of
blocks II and IV conditional on the effect of block III and vice
versa remained signiﬁcant (p(IIjIII) ¼ 0.023, p(IIIjII) ¼ 0.0004,
p(IVjIII) ¼ 0.003, and p(IIIjIV) ¼ 0.026), suggesting that multiple
variants in the region may jointly account for the observed
effect on CD. Commonly occurring recombinant haplotypes
in blocks II and III caused local drops in signiﬁcance, thus
suggesting that causal variants lie outside the corresponding
subsegments (Figure 2C).
No known genes or CpG islands were found within the
region of association on 5p13.1 after examination with the
Ensembl and UCSC genome browsers. The region has an
average GC content of 38%, and an excess of interspersed
repeats given GC content (58.36% versus 42.3%), which is
mainly due to an excess of LINE1 (33.05% versus 19.6%) and
LTR elements (15.36% versus 7.70%) [12]. It contains 98
highly conserved elements [13]. It is part of a 1.25-Mb gene
desert between DAB2 (850 kb distally from the block) and
PTGER4 (270 kb proximally from the block). Interestingly,
several of the genes ﬂanking the region have been implicated
in pathogenesis of CD, or are related to genes that have been
implicated in the disease. These include a member of the
caspase recruitment domain family (CARD6), three comple-
ment factors (C6, C7, and C9), and—most notably—the
prostaglandin receptor EP4 (PTGER4), which resides closest
to the group of disease associated markers (Figure S1).
Onehypothesisisthatthedisease-associatedregioncontains
cis-acting regulatory elements that control the expression
levels of the causal gene(s) located in the vicinity, and that the
causal variants modulate the activity of these elements. As a
ﬁrst step to test this, we studied the effect of SNPs in the
disease-associatedregionontheexpressionlevelsof neighbor-
inggenes.Tothatendweexploited adatabaseofgenome-wide
gene expression (Affymetrix HG-U133 Plus 2.0 chips; http://
www.affymetrix.com) measured in EBV-transformed lympho-
blastoid cell lines from 378 individuals genotyped with the
Illumina HumanHap300 Genotyping Beadchip (W. Cookson,
unpublished data). Remarkably, eight of the 26 Illumina
markers spanning 264 kb coinciding precisely with the CD-
associated region yielded p-values ,2 3 10
 3 for PTGER4
(Figure 2B). Three of the markers inﬂuencing PTGER4
expression are located in block III (rs16869977, rs10512739,
and rs6880934). The ﬁrst two are tagging the IIIBa sub-clade
(Figure2C),whilethethirdoneisincompleteLDwithit(IIIAþ
IIIBa). The corresponding SNPs did not show convincing
evidence for association with CD. Two strongly associated
SNPs (D9 ¼ 0.84) located respectively in block IV (rs4495224)
and V (rs7720838) showed the most signiﬁcant effect on
PTGER4expressionandwerealsoassociatedwithCD(Table1).
The rs4495224 A and rs7720838 T risk alleles were associated
with increased PTGER4 expression. Although these results
must be treated as preliminary, they tend to support the
hypothesis that the disease-associated polymorphisms may be
related to the expression levels of one or more genes in the
region.
CD is the most common form of inﬂammatory bowel
disease, the other being ulcerative colitis (UC). We genotyped
a cohort of 246 Belgian UC patients (Caucasians) for IL23R
(rs11209026), ATG16L1 (rs2241880), and the novel 5p13.1
locus (rs4613763). Consistent with published results [6,10] we
found a signiﬁcant association for IL23R (p¼1.2310
 3; odds
ratio: 2.51) but not for ATG16L1 (p ¼ 0.78). There was no
effect of the novel 5p13.1 locus on UC (p ¼ 0.54). While
additional studies will be needed to exclude completely a role
in UC, these results suggest that the principal susceptibility
effects of the 5p13.1 locus are for CD. The restriction to CD
risk observed for ATG16L1 and the 5p13.1 locus is similar to
that found for CARD15 [3].
We herein describe the localization of a novel major
susceptibility locus for CD on 5p13.1 by GWA. The region of
strongest association coincides with a gene desert devoid of
known protein-coding genes. The observed effect may be
mediated by as-yet unknown transcripts mapping within the
region. As a matter of fact, limited numbers of spliced and
unspliced ESTs originating from the HT1080 ﬁbrosarcoma
cell line or medulla (e.g., BG182136 and BG184600) map to
the region. An alternative explanation, however, is that the
disease-associated region contains cis-acting elements con-
trolling the expression of more distant genes. We provide
evidence in support of this hypothesis by demonstrating that
genetic variants in the CD-associated region differentially
regulate the expression levels of PTGER4, the closest known
gene located 270 kb proximally. PTGER4 is a strong candidate
gene for CD, as it is known that knock-out mice develop
severe colitis upon dextran sodium sulphate treatment,
unlike mice deﬁcient in any of the seven other types of
prostanoid receptors. Increased susceptibility to colitis is also
observed in wild-type mice administered an EP4-selective
antagonist, while EP4-selective agonists are protective [14].
We observe in particular that the CD susceptibility allele at
marker rs4495224 is associated with increased PTGER4
transcript levels in lymphoblastoid cell lines. This ﬁnding
establishes a direct link between disease susceptibility and
PTGER4 expression, although the direction of the effect
apparently contradicts the results in knock-out mice. De-
tailed studies of the effect of genetic variants in the disease-
associated region on PTGER4 expression in different tissues
and of a possible connection between PTGER4 levels and CD
susceptibility are certainly needed and work towards that goal
is in progress. The hypothesis that the 5p13.1 CD-suscepti-
bility locus operates by modulating PTGER4 expression levels
could—at least in theory—be tested by replacing the
corresponding murine sequences with the human ortholo-
gous variants and quantitatively complement the murine
knock-out allele [15]. Our results suggest that the 5p13.1
effect on CD could result from the combined action of
multiple susceptibility variants. Extensive sequencing of the
most common haplotypes in the region of association is being
conducted towards their identiﬁcation.
Materials and Methods
Genotyping. Genotyping for the whole genome scan was per-
formed on a Illumina HumanHap300 Genotyping Beadchip (http://
www.illumina.com) [4]. Genotyping of individual SNPs was performed
on an ABI7900HT Sequence Detection System using TaqMan MGB
probes from Pre-designed SNP Genotyping or Custom TaqMan SNP
Genotyping assays (Applied Biosystems, http://www.
appliedbiosystems.com).
Association analyses. Association analyses were conducted using
Fisher’s exact test (whole genome scan) or chi-squared tests of
independence (conﬁrmation analysis). We applied the logistic
regression method of Setakis et al. [5] to test for the possible effect
of population structure on the most signiﬁcant association results.
The 110 control markers included in the logistic regression had 100%
genotype success rate with minor allele frequency .30%, and no two
PLoS Genetics | www.plosgenetics.org April 2007 | Volume 3 | Issue 4 | e58 0542
Whole Genome Association for Crohn Diseasemarkers were within 20 Mb of one another. To test for an effect of
block I conditional on the effect of an adjacent block II, we compared
the proportion of I haplotype clades nested within a given II clade
(for instance, proportion of IA, IB and IC within IIA) between cases
and controls by chi-squared. Chi-squared values (and degrees of
freedom) were summed across II clades to yield an overall (IjII) test
statistic.
Expression database. The database genome-wide expression
analysis data was provided by W. Cookson (Imperial College, London,
United Kingdom). Brieﬂy, expression data were generated from RNA
extracted from EBV-transformed cells from 378 genotyped offspring
in nuclear families. Annotations for individual transcripts on the
Affymetrix arrays were extracted from the Affymetrix NetAffx
database (http://www.affymetrix.com). Data from the gene expression
experiment was normalized together using the RMA (Robust Multi-
Array Average) package [16,17] to remove any technical or spurious
background variation. An inverse normalization transformation step
was also applied to each trait to avoid any outliers. A variance
components method was used to estimate heritability of each trait
using Merlin-regress (RandomSample option) [18, 19]. For PTGER4,
we obtained a mean quantitative expression value of  0.017 and a
variance of 0.722 while the heritability estimate for PTGER4
estimated using the sibship data was 0.844. Association analysis was
applied with Merlin (FASTASSOC option). We estimated an additive
effect for SNPs and tested its signiﬁcance using a score test that
adjusts for familiality and takes into account uncertainty in the
inference of missing genotypes.
Supporting Information
Figure S1. Log(p) Values for Illumina SNPs Located in a ;2-Mb
Region Centered around the 122-kb Block III (Marked by Solid
Vertical Lines) Described in Detail in Figure 2
Found at doi:10.1371/journal.pgen.0030058.sg001 (418 KB PPT).
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